Filters

See more specimen types...

Other countries

Results: 1 to 11 of 11

Tests names and labsConditionsGenes and analytesMethods

Whole Pharmacogenomics Scan

RPRD Diagnostics, LLC
United States
9866
  • T Targeted variant analysis

Admera Health PGxOne Plus comprehensive test

Admera Health
United States
12642
  • T Targeted variant analysis

MedMPact

Genelex
United States
3324
  • D Deletion/duplication analysis
  • T Targeted variant analysis

NAT2

Genelex
United States
11
  • T Targeted variant analysis

Slow acetylator due to N-acetyltransferase enzyme variant

Labor Dr. Wisplinghoff
Germany
11
  • T Targeted variant analysis

Pharmacogenetic panel

bio.logis Center for Human Genetics Diagnosticum
Germany
4629
  • T Targeted variant analysis

Pharmacogenetics (NAT2 polymorphisms)

CGC Genetics
Portugal
11
  • T Targeted variant analysis

NAT2

MVZ Dortmund Dr. Eberhard & Partner
Germany
11
  • C Sequence analysis of the entire coding region

NAT2 Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clinical Exome

Fulgent Genetics
United States
51504673
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

NAT2 (N-Acetylransferase): *5A, *6A, and *7A alleles screening

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
11
  • E Sequence analysis of select exons

Results: 1 to 11 of 11

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center